首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: Inverse association with positive symptoms
【24h】

Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: Inverse association with positive symptoms

机译:首次发作和未接受药物治疗的精神分裂症患者血浆超氧化物歧化酶升高:与阳性症状呈负相关

获取原文
获取原文并翻译 | 示例
       

摘要

Excessive free radical production or oxidative stress may be involved in the pathophysiology of schizophrenia as evidenced by increased superoxide dismutase (SOD) activities, a critical enzyme in the detoxification of superoxide radicals. This study compared plasma SOD activities in 78 never-medicated first-episode and 100 medicated chronic schizophrenia patients to 100 healthy control subjects and correlated these SOD activities with the Positive and Negative Syndrome Scale (PANSS) among the schizophrenic patients. We found that both first-episode and chronic patients had significantly increased plasma SOD activities compared to controls, and that chronic schizophrenic patients on antipsychotic medication had significantly higher SOD activities than first episode schizophrenic patients. Plasma SOD activities were also negatively correlated with positive symptoms of schizophrenia, but only in first-episode patients. Thus, oxidative stress appears to be greater in first episode schizophrenic patients with fewer positive symptoms and may become greater as schizophrenia becomes more chronic, although we cannot exclude the possibility that chronic antipsychotic treatment may increase SOD activities and presumed oxidative stress in schizophrenia.
机译:精神分裂症的病理生理可能涉及过多的自由基产生或氧化应激,这可通过增加的超氧化物歧化酶(SOD)活性来证明,SOD活性是超氧化物自由基解毒的关键酶。这项研究比较了78例从未服用过药物的初发患者和100例含药的慢性精神分裂症患者与100名健康对照者的血浆SOD活性,并将这些SOD活性与精神分裂症患者的正负综合症量表(PANSS)进行了关联。我们发现,与对照组相比,首发和慢性患者的血浆SOD活性均显着增加,并且服用抗精神病药物的慢性精神分裂症患者的SOD活性明显高于首次发作的精神分裂症患者。血浆SOD活性也与精神分裂症的阳性症状呈负相关,但仅在首发患者中。因此,在精神分裂症首发的阳性症状较少的精神分裂症患者中,氧化应激似乎更大,并且随着精神分裂症变得更加慢性而可能变得更大,尽管我们不能排除长期的抗精神病药物治疗可能会增加精神分裂症中SOD活性和假定的氧化应激的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号